Morgan Stanley’s Bio-Path Holdings Inc BPTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-35
| Closed | -$41 | – | 8345 |
|
|
2024
Q4 | $41 | Hold |
35
| – | – | ﹤0.01% | 7689 |
|
|
2024
Q3 | $32 | Hold |
35
| – | – | ﹤0.01% | 7725 |
|
|
2024
Q2 | $70 | Hold |
35
| – | – | ﹤0.01% | 7422 |
|
|
2024
Q1 | $144 | Sell |
35
-35
| -50% | -$264 | ﹤0.01% | 7339 |
|
|
2023
Q4 | $648 | Buy |
70
+35
| +100% | +$368 | ﹤0.01% | 7253 |
|
|
2023
Q3 | $259 | Hold |
35
| – | – | ﹤0.01% | 7368 |
|
|
2023
Q2 | $1.25K | Hold |
35
| – | – | ﹤0.01% | 7267 |
|
|
2023
Q1 | $973 | Hold |
35
| – | – | ﹤0.01% | 7360 |
|
|
2022
Q4 | $1.06K | Hold |
35
| – | – | ﹤0.01% | 7460 |
|
|
2022
Q3 | $2K | Sell |
35
-443
| -93% | -$33.6K | ﹤0.01% | 7505 |
|
|
2022
Q2 | $37K | Buy |
478
+453
| +1,812% | +$30.6K | ﹤0.01% | 6753 |
|
|
2022
Q1 | $2K | Sell |
25
-946
| -97% | -$69K | ﹤0.01% | 7782 |
|
|
2021
Q4 | $73K | Sell |
971
-86
| -8% | -$7.96K | ﹤0.01% | 6622 |
|
|
2021
Q3 | $108K | Buy |
1,057
+992
| +1,526% | +$119K | ﹤0.01% | 6324 |
|
|
2021
Q2 | $9K | Sell |
65
-1,933
| -97% | -$238K | ﹤0.01% | 7276 |
|
|
2021
Q1 | $281K | Buy |
1,998
+1,902
| +1,981% | +$225K | ﹤0.01% | 5468 |
|
|
2020
Q4 | $7K | Sell |
96
-8
| -8% | -$600 | ﹤0.01% | 6725 |
|
|
2020
Q3 | $9K | Buy |
104
+53
| +104% | +$4.96K | ﹤0.01% | 6314 |
|
|
2020
Q2 | $5K | Sell |
51
-38
| -43% | -$3.94K | ﹤0.01% | 6311 |
|
|
2020
Q1 | $8K | Sell |
89
-160
| -64% | -$19K | ﹤0.01% | 6090 |
|
|
2019
Q4 | $40K | Buy |
249
+148
| +147% | +$27.8K | ﹤0.01% | 5921 |
|
|
2019
Q3 | $19K | Sell |
101
-897
| -90% | -$223K | ﹤0.01% | 6035 |
|
|
2019
Q2 | $267K | Buy |
998
+993
| +19,860% | +$315K | ﹤0.01% | 4894 |
|
|
2019
Q1 | $2K | Buy |
+5
| New | +$919 | ﹤0.01% | 6481 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6782 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6735 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6690 |
|
|
2017
Q3 | – | Sell |
-12
| Closed | -$16.5K | – | 6646 |
|
|
2017
Q2 | $19K | Sell |
12
-17
| -59% | -$35.6K | ﹤0.01% | 6106 |
|
|
2017
Q1 | $96K | Sell |
29
-35
| -55% | -$127K | ﹤0.01% | 5619 |
|
|
2016
Q4 | $348K | Buy |
64
+60
| +1,500% | +$291K | ﹤0.01% | 5113 |
|
|
2016
Q3 | $23K | Buy |
+4
| New | +$25.7K | ﹤0.01% | 5874 |
|
|
2016
Q2 | – | Sell |
-1
| Closed | -$15K | – | 6696 |
|
|
2016
Q1 | $15K | Sell |
1
-1
| -50% | -$6.48K | ﹤0.01% | 6023 |
|
|
2015
Q4 | $9K | Sell |
2
-7
| -78% | -$40.8K | ﹤0.01% | 6271 |
|
|
2015
Q3 | $43K | Buy |
9
+7
| +350% | +$32.8K | ﹤0.01% | 5797 |
|
|
2015
Q2 | $8K | Sell |
2
-5
| -71% | -$27.3K | ﹤0.01% | 6345 |
|
|
2015
Q1 | $49K | Buy |
7
+4
| +133% | +$33.6K | ﹤0.01% | 5803 |
|
|
2014
Q4 | $33K | Buy |
3
+1
| +50% | +$10.3K | ﹤0.01% | 5929 |
|
|
2014
Q3 | $18K | Sell |
2
-35
| -95% | -$338K | ﹤0.01% | 6042 |
|
|
2014
Q2 | $447K | Buy |
37
+35
| +1,750% | +$384K | ﹤0.01% | 4666 |
|
|
2014
Q1 | $19K | Buy |
+2
| New | +$25K | ﹤0.01% | 5977 |
|
Other funds holding BPTH
Morgan Stanley's BPTH Position: Q1 2025 in Review
Morgan Stanley sold out of Bio-Path Holdings Inc (BPTH) in Q1 2025, closing a stake of 35 shares — an estimated $41 sold.
Morgan Stanley first reported a position in BPTH in Q1 2014 and held it in 37 quarters. The position peaked at $447K in Q2 2014. 2 funds tracked by Wall St. Rank hold BPTH as of Q1 2025.
- Morgan Stanley reported no remaining Bio-Path Holdings Inc position as of Q1 2025 after selling out during the quarter.
- Morgan Stanley sold 35 Bio-Path Holdings Inc shares in Q1 2025, an estimated $41.
- Morgan Stanley first reported a position in Bio-Path Holdings Inc in Q1 2014 and held it in 37 quarters.
- Morgan Stanley's Bio-Path Holdings Inc position peaked at $447K in Q2 2014.
- 2 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q1 2025.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.